Relating to informed consent for certain screening tests.

SB 2916 requires healthcare providers to obtain patient consent before performing blood screening for sexually transmitted diseases (STDs) and to inform patients they can opt out of the test. It mandates that providers explain the screening process and offer information about available health services if a patient receives a positive result. The law applies to medical screenings for STDs and takes effect January 1, 2026, with the Health and Human Services Commission required to adopt implementing rules by that date. This bill directly affects healthcare providers who conduct STD screenings and patients receiving those screenings.